Radioimmunotherapy of melanoma with novel LGG to melanin

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201600017C
Awardee
Awarding agency
Obligated
$295,782

Award facts

Opportunity
  • PH201601 Solicitation number
Contract value 100% obligated
$295,782.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 12 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Los Angeles, CA 90024, USA
Research
SBIR Program Phase I Action

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope 1 $0
Original award $295,782

About this award

This is a $295,782 firm fixed price contract awarded by the National Cancer Institute (NCI), a civilian agency, to Radimmune Therapeutics, Inc., a self-certified small disadvantaged business. The contract is for a Small Business Innovation Research (SBIR) Program Phase I project focused on "RADIOIMMUNOTHERAPY OF MELANOMA WITH NOVEL LGG TO MELANIN". The contract has a completion date of September 18, 2017 and was awarded on September 19, 2016. The contract is designated as a total small business set-aside.

Quick answers

Who was awarded contract HHSN261201600017C?

HHSN261201600017C was awarded to Radimmune Therapeutics, Inc. by National Cancer Institute (National Institutes of Health) on September 19, 2016.

How much is contract HHSN261201600017C worth?

The government has obligated $295,782 on HHSN261201600017C.

Was contract HHSN261201600017C competed?

The extent of competition for HHSN261201600017C was full and open competition after exclusion of sources. The government received 12 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award